Biological TherapyBiological ProductsAntirheumatic AgentsArthritis, RheumatoidAntibodies, MonoclonalPsoriasisPhenetidineArthritis, PsoriaticAntibodies, Monoclonal, HumanizedImmunologic FactorsDermatologic AgentsSpondylarthritisReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaRheumatic DiseasesAntibodies, Monoclonal, Murine-DerivedTreatment OutcomeImmunoglobulin GImmune SystemOff-Label UseSchizophrenia, CatatonicImmunotherapyAnti-Inflammatory AgentsNeoplasmsGastrointestinal AgentsClinical Trials as TopicInflammatory Bowel DiseasesCrohn DiseaseImmunosuppressive AgentsImmunoconjugatesDisease ProgressionAutoimmune DiseasesEarly Detection of CancerAntineoplastic AgentsModels, BiologicalCytokinesArthritis, JuvenileSeverity of Illness IndexMethotrexateRetrospective StudiesPrognosisGenetic TherapyT-LymphocytesSpondylitis, AnkylosingInterleukin 1 Receptor Antagonist ProteinBiological MarkersTime FactorsProstatic NeoplasmsBreast NeoplasmsOvarian NeoplasmsUnited StatesAntineoplastic Combined Chemotherapy ProtocolsCost-Benefit AnalysisLung NeoplasmsImmune ToleranceDisease Models, AnimalAnti-Inflammatory Agents, Non-SteroidalGene Expression ProfilingColonic Neoplasms